By year’s end, the FDA may approve the first oral GLP-1 pill — a 25 mg daily dose of semaglutide…
Browsing: Clinical Updates
The first half of 2025 has brought major developments in gastroenterology, spanning new drug approvals, trial data, and clinical guidance.…
At the 2025 ASCO GI Spotlight, Dr. Anita Turk, a medical oncologist at IU Health, highlighted promising developments in colorectal…
Researchers at the University of Chicago have developed a next-generation liquid biopsy test that detects early-stage colorectal cancer with 95%…
Exact Sciences has announced a major milestone: its Oncodetect™ MRD test for colorectal cancer has secured Medicare coverage through CMS’s…
A new chapter published by Springer Nature dives deep into one of the most promising frontiers in oncology: the use…
In a breakthrough from Germany’s Hahn-Schickard Institute, researchers have developed a new blood test for early-onset colorectal cancer that requires…
A new multi-cancer early detection (MCED) test profiled in Medscape claims to detect 13 types of cancer—including hard-to-screen cancers like…
GLP-1 receptor agonists are revolutionizing treatment for diabetes and obesity, but their impact on the gastrointestinal tract demands careful clinical…
Diagnosing celiac disease might soon become significantly easier. A team from Australia’s Walter and Eliza Hall Institute has developed a…